Innovative drug sector strengthens, Shutaishen leads in gains

MaticHoleFiller · 2026-03-28T05:59:06+00:00

The innovative drug sector performed strongly, with several stocks hitting the daily limit or showing significant gains, including Wanbangde, Lianhuan Pharmaceutical, and others. However, investors should exercise caution, as there are risks in the market. This information is for reference only.

MaticHoleFiller

2026-03-28 05:59:06

Abstract generation in progress

March 27 news, as of 11:15, the innovative drug sector has strengthened, with Wanbangde, Lianhuan Pharmaceutical, Zhaoyan New Drug, and Kanghong Pharmaceutical reaching the daily limit. Shutaishen, Hite Bio, Xinruowei, Kelun Pharmaceutical, Beilu Pharmaceutical, and Puris are among the stocks with significant gains.

Statement: The market carries risks; investment should be cautious. This article is automatically published based on third-party databases and does not represent the views of Sina Finance. Any information appearing in this article is for reference only and does not constitute personal investment advice. Please refer to actual announcements for discrepancies. If you have any questions, please contact biz@staff.sina.com.cn.

For a wealth of information and precise interpretations, check out the Sina Finance APP.

Editor: Xiaolang Express News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.